| Bioactivity | BP Lipid 142 is derived from patent WO2018170306A1 (Example 102). BP Lipid 142 is an ionizable amine lipid analogous to SM-102. The propanolamine head improves encapsulation of mRNA. The lipid has both esters at C6 and C8 position relative to the amine nitrogen. Ester linkages in the lipid tails are introduced into the structure to improve tissue clearance. The primary ester located at C6 is attached with a long (11-carbon) lipid tail. The lipid can be used for mRNA-based therapies. |
| CAS | 2244715-87-3 |
| Formula | C45H89NO5 |
| Molar Mass | 724.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Compounds and compositions for intracellular delivery of therapeutic agents. WO2018170306A1 |
BP Lipid 142
CAS: 2244715-87-3 F: C45H89NO5 W: 724.19
BP Lipid 142 is derived from patent WO2018170306A1 (Example 102). BP Lipid 142 is an ionizable amine lipid analogous to
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.